Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

503.86
-2.9600-0.58%
Post-market: 503.860.00000.00%19:30 EDT
Volume:653.16K
Turnover:328.55M
Market Cap:21.61B
PE:18.03
High:509.79
Open:502.44
Low:497.91
Close:506.82
52wk High:609.35
52wk Low:395.00
Shares:42.89M
Float Shares:39.35M
Volume Ratio:0.98
T/O Rate:1.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.38
PE(LYR):18.09

Loading ...

MannKind Buy Rating Reiterated as United Therapeutics Expands DPI Partnership; $8 Price Target Unchanged

TIPRANKS
·
May 07

BUZZ-U.S. STOCKS ON THE MOVE-Walt Disney, CVS, Uber

Reuters
·
May 06

United Therapeutics Q1 Earnings, Revenue Fall

MT Newswires Live
·
May 06

BUZZ-MannKind rises as it partners with United Therapeutics on inhaled drug for rare lung disease

Reuters
·
May 06

Earnings Flash (UTHR) United Therapeutics Posts Q1 EPS $5.82, vs. FactSet Est of $6.91

MT Newswires Live
·
May 06

MannKind Corp - Eligible for up to $35 Mln in Milestones and 10% Royalties on Net Sales

THOMSON REUTERS
·
May 06

MannKind Corp - Announces Development of Ralinepag Dry Powder Inhalation for United Therapeutics

THOMSON REUTERS
·
May 06

United Therapeutics Q1 FY26 net income drops 15% to $274.9 million; revenue slips 2% to $781.5 million

Reuters
·
May 06

BRIEF-United Therapeutics Q1 Revenue USD 781.5 Million Vs. IBES Estimate USD 796.9 Million

Reuters
·
May 06

United Therapeutics Corporation Reports First Quarter 2026 Financial Results

THOMSON REUTERS
·
May 06

United Therapeutics Q1 EPS USD 5.82

THOMSON REUTERS
·
May 06

United Therapeutics CFO James Edgemond disposes 10,000 shares for $5.77 million

Reuters
·
May 06

United Therapeutics CEO Martine Rothblatt disposes of shares worth $5.41 million

Reuters
·
May 05

United Therapeutics CEO Martine Rothblatt disposes of common shares worth $5.41 million

Reuters
·
May 02

United Therapeutics CFO James Edgemond disposes of shares worth $5.01 million

Reuters
·
May 02

United Therapeutics CEO Martine Rothblatt disposes of shares worth $3.37 million

Reuters
·
May 01

United Therapeutics announces retirement of Professor Dwek from board

TIPRANKS
·
Apr 29

Earning Preview: United Therapeutics this quarter’s revenue is expected to increase by 9.51%, and institutional views are bullish

Earnings Agent
·
Apr 29

United Therapeutics director Raymond Dwek retires from board, term ends June 26, 2026

Reuters
·
Apr 29

United Therapeutics Corporation Announces Retirement of Professor Raymond Dwek, C.b.e., F.r.s., From Its Board of Directors

THOMSON REUTERS
·
Apr 29